Globally, infertility rates are rising, including in Bangladesh, leading to increasing demand for in vitro fertilisation (IVF) treatment. However, due to its high cost, this advanced medical procedure remains inaccessible to many couples. Medical experts suggest that incorporating IVF into insurance coverage could improve accessibility and potentially enhance treatment outcomes.
IVF is a multi-stage assisted reproductive technology involving ovarian stimulation, egg retrieval, fertilisation in a laboratory setting, and embryo transfer. A single cycle typically takes around two to three weeks to complete. However, achieving pregnancy often requires multiple cycles, depending on individual medical circumstances.
Clinical data indicate that IVF success rates vary significantly by age. For women under 35, the average success rate per cycle is approximately 50–55 per cent. This figure declines to around 20–30 per cent for women aged between 38 and 40, with further reduction as age increases.
Despite its effectiveness, IVF remains financially burdensome. In the United States, the cost of a single cycle ranges from USD 12,000 to USD 30,000, excluding medication and additional procedures. In Europe, although costs are generally lower, they still amount to several thousand euros per cycle. As a result, many patients delay or discontinue treatment due to financial constraints.
Medical specialists identify cost as the principal barrier to infertility treatment. Many couples begin IVF but are unable to complete the recommended course due to financial pressure. In this context, insurance coverage is increasingly viewed as a potential solution. In countries where IVF is partially or fully covered by insurance systems, patients are more likely to complete treatment cycles. Such coverage is also associated with safer clinical practices, including the transfer of fewer embryos, thereby reducing the risk of multiple pregnancies.
In the United States, certain states mandate insurance coverage for infertility treatment, although restrictions often apply, including limits on the number of cycles or total expenditure. In several European countries, public healthcare systems provide broader coverage. For example, in the Netherlands, up to three IVF or intracytoplasmic sperm injection (ICSI) cycles may be covered under specific conditions.
In Bangladesh, the situation differs significantly. IVF treatment is almost entirely financed out-of-pocket. While several private clinics offer advanced reproductive services, no insurance provider currently includes IVF in standard health insurance policies. Industry analysts attribute this to limited product innovation within the insurance sector and the relatively low penetration of comprehensive health insurance.
Experts argue that introducing IVF insurance could generate dual benefits: improved access to essential reproductive healthcare and expansion of the insurance market. With growing awareness of infertility issues, corporate employers and insurers may in future consider fertility-related benefits as part of employee health packages.
Comparative Overview of IVF Access and Costs
| Region / Country | IVF Cost per Cycle | Insurance Coverage | Notes |
|---|---|---|---|
| United States | USD 12,000–30,000 | Partial (varies by state) | Limits on cycles or spending in some states |
| Europe (general) | Several thousand euros | Partial to substantial (varies by country) | Public healthcare support in some systems |
| Netherlands | Not specified (covered cycles) | Up to 3 cycles under conditions | Includes IVF/ICSI under public scheme |
| Bangladesh | High relative to income | Not included in insurance policies | Mostly out-of-pocket in private clinics |
For many couples, the expansion of IVF insurance coverage could represent not only financial relief but also a greater likelihood of completing treatment and achieving parenthood after prolonged uncertainty.